Oligonucleotides comprising alternating segments and uses thereof
CA 2474414 C · Owner: Mcgill University · Inventors: Damha, Masad J.; Parniak, Michael A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to oligonucleosides having alternating segments of sugarmodified nucleosides and 2~-deoxynucleosides and uses thereof. The invention , further relates to oligonucleotides having alternating segments of sugarmodified nucleotides and 2~-deoxynucleotides and uses thereof. Such uses , include the preparation of antisense oligonucleotides and their use for the prevention or depletion of function of a target nucleic acid of interest such , as an RNA, in a system. Accordingly an oligonucleotide of the invention is useful for therapeutic, analytical and diagnostic methods and uses as well as , a component of compositions and commercial packages corresponding to such methods …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 31, 2003 and granted March 6, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 31, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 31, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.